Back to Journals » International Journal of Nanomedicine » Volume 11

A combination of sorafenib and nilotinib reduces the growth of castrate-resistant prostate cancer

Total article views   Abstract views HTML views PDF downloads Totals
8,111 Dovepress* 4,120 3,035+ 1,125 7,155
PubMed Central* 0 956 283 956
Totals 4,120 3,991 1,408 8,111
*Since 8 January 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
8 0 0 0 4 4

View citations on PubMed Central and Google Scholar